PRIMARY SJOGREN'S SYNDROME
Clinical trials for PRIMARY SJOGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJOGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for PRIMARY SJOGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on childhood arthritis and autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new treatment using specially engineered immune cells (CAR-T cells) in 11 children with severe rheumatic diseases like juvenile dermatomyositis, arthritis, and scleroderma that haven't responded to standard therapies. The goal is to see if thes…
Matched conditions: PRIMARY SJOGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated May 17, 2026 07:06 UTC
-
Experimental CAR-T therapy targets tough autoimmune cases
Disease control Recruiting nowThis early-phase study tests a new treatment called OL-CD19-GDT, which uses specially engineered immune cells (CAR-T cells) from a healthy donor to target and destroy faulty immune cells in people with severe, treatment-resistant autoimmune diseases like systemic sclerosis and Sj…
Matched conditions: PRIMARY SJOGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 11, 2026 20:38 UTC